Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

NCT06453213 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Focal Onset Seizure

Interventions

DRUG: Cenobamate

Sponsor

SK Life Science, Inc.